The drugmaker said it had started early-stage human trials in the United States and Belgium and would test its vaccine candidate in more than 1,000 healthy adults aged 18 to 55 years, as well as adults aged 65 years and older.
from Hindustan Times - world https://ift.tt/3hTmPlc
No comments:
Post a Comment